US Stock MarketDetailed Quotes

PACB Pacific Biosciences of California

Watchlist
  • 1.450
  • -0.010-0.68%
Close Feb 28 16:00 ET
  • 1.460
  • +0.010+0.69%
Post 19:55 ET
426.76MMarket Cap-0.92P/E (TTM)

Pacific Biosciences of California Key Stats

Pacific Biosciences of California Q4 2024 Earnings Date

Currency:USDFeb 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
40.68M
39.22M
-1.46M
Miss Est.
-30.29%
-32.79%
-3.58%
EPS
-0.22
-0.49
-0.27
Miss Est.
+29.85%
-58.06%
-125.39%
Buy

Mar 1, 2025

Pacific Biosciences of California Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 38.094M--
--2025/Q1-- / 33.662M--
Feb 13, 20252024/Q439.224M / 40.681M--
Nov 7, 20242024/Q339.967M / 41.860M--
Aug 7, 20242024/Q236.013M / 41.019M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 38.094M--
--2025/Q1-- / 33.662M--
Feb 13, 20252024/Q439.224M / 40.681M--
Nov 7, 20242024/Q339.967M / 41.860M--
Aug 7, 20242024/Q236.013M / 41.019M--

Unlock Free Earnings Estimates

Pacific Biosciences of California Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 1, 2025

Buy

  • Buy

    42.86%
  • Hold

    57.14%
  • Sell

    0.00%

Price Target

No Data